Migraines are debilitating. A landmark new clinical trial – the first of its kind – tested whether cannabis could actually help.
When a Headache Isn’t Just a Headache
A migraine is not a bad headache. It’s a neurological event – throbbing pain, often on one side of the head, frequently accompanied by nausea, vomiting, and extreme sensitivity to light and sound. For the roughly 39 million Americans who experience migraines, a bad attack can mean hours or even days lost to a darkened room.
Existing medications don’t work for everyone. Some cause rebound headaches with overuse. Others can’t be taken by people with cardiovascular conditions. The need for new, effective treatments is real and urgent.
That’s what makes a new study published in Headache (2025/2026) so significant. For the first time in medical history, researchers conducted a randomized, double-blind, placebo-controlled crossover trial of vaporized cannabis for acute migraine treatment.
The Study
Led by Dr. Nathaniel M. Schuster at the University of California, San Diego Center for Pain Medicine, the study enrolled 92 participants with confirmed migraine.
Each participant treated up to four separate migraine attacks – one each with:
- A THC-dominant cannabis flower (~6% THC)
- A CBD-dominant cannabis flower (~12% CBD)
- A THC + CBD combination (~6% THC / ~11% CBD)
- A placebo (cannabis with ~0% THC and ~0% CBD)
Crucially, neither participants nor researchers knew which treatment was being used for which attack – maintaining the blind. Outcomes were assessed at 2 hours, 24 hours, and 48 hours post-vaporization, following International Headache Society guidelines.
The Results
The headline finding was striking: THC + CBD was superior to placebo for pain relief, pain freedom, and most bothersome symptom (MBS) freedom at 2 hours. Benefits were sustained at 24 and 48 hours for several key outcomes.
CBD-dominant cannabis alone was not superior to placebo for the primary outcomes. THC-dominant cannabis showed some pain relief benefit, but not full pain freedom.
Importantly, no serious adverse events were reported across the entire trial.
Why This Matters
The combination of CBD and THC working together illustrates the well-documented “entourage effect” – the idea that cannabinoids work synergistically, producing greater benefits together than either compound alone. For CBD users who have never considered full-spectrum products with trace THC, this study adds meaningful evidence to the case for whole-plant formulations.
This is also simply historic. Before this study, every claim about cannabis helping migraines was based on surveys, anecdotes, or uncontrolled observations. Now, there is genuine randomized controlled trial evidence.
Practical Takeaways
- The winning formulation was THC + CBD combined – supporting the case for full-spectrum CBD products over CBD isolate for conditions involving acute pain and neurological symptoms
- Vaporization was the delivery method studied – it offers a faster onset than oral CBD, though it’s not the right format for everyone
- If you use CBD for headache or migraine support, speak with your healthcare provider about the evolving evidence and what product formats may be most appropriate for you
About the Original Study
Title: Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial Year: 2025 (published online Dec. 30, 2025) Journal: Headache DOI: 10.1111/head.70025 PubMed: https://pubmed.ncbi.nlm.nih.gov/41469488/
Authors:
- Nathaniel M. Schuster, MD – Board-certified neurologist and pain/headache specialist; Associate Clinic Director, UC San Diego Center for Pain Medicine. Principal investigator of the first placebo-controlled cannabinoid migraine trial.
- Mark S. Wallace, MD – UC San Diego Department of Anesthesiology.
- Thomas D. Marcotte, PhD – Center for Medicinal Cannabis Research, UC San Diego.
- Dawn C. Buse, PhD – Albert Einstein College of Medicine, leading headache researcher.
- Euyhyun Lee, MSc – Biostatistics, UC San Diego.
- Lin Liu, PhD – Department of Family Medicine, UC San Diego.
- Michelle Sexton, ND – Center for Medicinal Cannabis Research, UC San Diego.
Contributing Expert
Alan first discovered CBD while recovering from a sports injury — and he’s been a believer ever since. Over the years, he’s used CBD for sleep, skincare, easing anxiety, and even helping his family pet stay calm. With more than 20 years of experience running a marketing business, Alan now enjoys sharing scientific studies and personal experience with customers at Flourish + Live Well.